GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Vilanterol + Fluticasone Furoate Inhaler 12.5+100mcg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

Vilanterol + Fluticasone Furoate Inhaler 12.5+100mcg
Each actuation delivers
Vilanterol Trifenatate
equivalent to Vilanterol ……………………12.5 mcg
Fluticasone Furoate Ph.Eur………………………………..100mcg
Suspended in inert propellant………..q.s.

THERAPEUTIC INDICATIONS:

The combination of fluticasone and vilanterol is used to control wheezing, shortness of breath, coughing, and chest tightness caused by asthma and chronic obstructive pulmonary (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema) in adults.

CAUTION & SCHEDULE:

CAUTION: Keep away from eyes. Keep away from children
Pressurised canister keep away from heat and light.
.do not puncture, break or burn.
Do not exceed the recommended dose
.Shake well before use.
Always replace the dust cap.
SCHEDULE:Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store below 30 °C.
Do not Freeze
Protected from moisture.
Dosage: Refer to the enclosed leaflet before use.
As directed by Physician

Vilanterol + Fluticasone Furoate Inhaler 12.5+100mcg Technical Specification:

Product Name:Vilanterol + Fluticasone Furoate Inhaler 12.5+100mcg
Brand Name:Generics
Strength:12.5+100mcg
Dosage Form:Inhalers
Packing:120 Metered Dose
Route of Administration:Drugs administered by inhalation through the mouth.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Long-Acting β Agonists + Corticosteroids
Indication: The combination of fluticasone and vilanterol is used to control wheezing, shortness of breath, coughing, and chest tightness caused by asthma and chronic obstructive pulmonary (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema) in adults.
Storage:Store below 30 °C. Do not Freeze.Protected from moisture.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Vilanterol + Fluticasone Furoate Inhaler 12.5+100mcg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Vilanterol + Fluticasone Furoate Inhaler 12.5+100mcg
    Each actuation delivers
    equivalent to Vilanterol ……………………12.5 mcg
    Fluticasone Furoate Ph.Eur………………………………..100mcg
    Suspended in inert propellant………..q.s.

THERAPEUTIC INDICATION:

The combination of fluticasone and vilanterol is used to control wheezing, shortness of breath, coughing, and chest tightness caused by asthma and chronic obstructive pulmonary (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema) in adults.

CAUTION & SCHEDULE:

CAUTION:Keep away from eyes.
Keep away from children
Pressurized canister keep away from heat and light.
Do not puncture, break or burn.
Do not exceed the recommended dose.
Shake well before use.
Always replace the dust cap.
SCHEDULE:Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage:Store below 30 °C.
Do not Freeze.
Protected from moisture.
Dosage:Refer to the enclosed leaflet before use.
As directed by Physician.